Related Experiment Video
Updated: Dec 20, 2025

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
Non-coding RNA in bladder cancer
Yi Li1, Gang Li1, Xiangyang Guo1
1Department of Anesthesiology, Peking University Third Hospital (PUTH), Beijing, China.
Abstract:
Bladder cancer is the tenth most common cancer worldwide and has been associated with high mortality and morbidity. Although the treatment of bladder cancer is based on well-defined tumor classifications and gradings, patients still experience different clinical response. The heterogeneity of this disease calls for substantial research with more in-depth molecular characterization, with the hope of identifying new diagnostic and treatment options. In recent years, non-coding RNAs (ncRNAs), particularly, microRNAs (miRNAs), long non-coding RNA (lncRNAs), and circular RNAs (circRNAs) were found to be associated with bladder cancer occurrence and development. This review highlights the recent findings concerning ncRNAs and their relevance to the pathogenesis of bladder cancer. This may provide a foundation for developing highly specific diagnostic tools and more robust therapeutic strategies in the future.
Insights
Non-coding RNAs (ncRNAs) like microRNAs and long non-coding RNAs are linked to bladder cancer development. Understanding these molecules could lead to better diagnostic and treatment options for this common cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Bladder cancer is a significant global health concern, ranking tenth in incidence, with considerable mortality and morbidity.
- Current treatment strategies for bladder cancer rely on established classifications and gradings, yet patient responses vary significantly, indicating underlying disease heterogeneity.
- This variability underscores the need for deeper molecular insights to discover novel diagnostic markers and therapeutic targets.
Purpose of the Study:
- To review recent advancements in understanding the role of non-coding RNAs (ncRNAs) in bladder cancer pathogenesis.
- To explore the potential of ncRNAs as biomarkers for diagnosis and as therapeutic targets for bladder cancer.
Main Methods:
- Comprehensive literature review of recent studies on non-coding RNAs (ncRNAs) in bladder cancer.
- Analysis of findings related to microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in bladder cancer occurrence and progression.
Main Results:
- Emerging evidence implicates various classes of ncRNAs, including miRNAs, lncRNAs, and circRNAs, in the development and progression of bladder cancer.
- These ncRNAs exhibit altered expression patterns in bladder cancer, suggesting their involvement in key cellular processes.
- The specific roles of different ncRNAs in bladder cancer pathogenesis are increasingly being elucidated.
Conclusions:
- Non-coding RNAs are critically involved in the molecular mechanisms underlying bladder cancer.
- Further research into ncRNAs offers a promising avenue for developing more precise diagnostic tools and effective therapeutic strategies for bladder cancer.
- Targeting ncRNAs may represent a future direction for personalized medicine in bladder cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
RNA Splicing
MicroRNAs
MicroRNAs
Types of RNA
RNA Performs Diverse...
